Sponsor or institution
Clinical trials and research at Fimbrion Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $900,001 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New oral drugs for tuberculosis from Thiazolino-Pyridone compounds
A small-molecule drug project seeks to develop an oral treatment for tuberculosis, including drug-resistant TB, to shorten and improve therapy.
-
Small Molecule Glycoside Inhibitors to Fight Pseudomonas Infections
A small molecule drug candidate is being developed to block a key bacterial target and help treat infections caused by Pseudomonas aeruginosa, including in people with lung conditions like CF or COPD.
-
New small-molecule drugs to treat nontuberculous mycobacterial infections
A health-focused small-molecule project is developing new drugs to treat stubborn NTM lung infections in people with weakened immunity or preexisting lung disease.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.